First-line immune-chemotherapy combination for squamous NSCLC is already a reality.

ABSTRACT:

SUBMITTER: Hendriks LEL 

PROVIDER: S-EPMC7354107 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature